| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 58.96B | 56.33B | 55.27B | 52.90B | 43.86B | 36.52B |
| Gross Profit | 18.91B | 17.94B | 17.14B | 17.32B | 14.34B | 11.20B |
| EBITDA | 13.08B | 12.43B | 12.29B | 13.14B | 9.88B | 7.69B |
| Net Income | 2.80B | 2.66B | 5.59B | 5.54B | 3.91B | 2.14B |
Balance Sheet | ||||||
| Total Assets | 90.88B | 91.70B | 96.86B | 82.49B | 73.15B | 63.94B |
| Cash, Cash Equivalents and Short-Term Investments | 24.37B | 24.31B | 26.69B | 18.64B | 14.07B | 14.26B |
| Total Debt | 12.08B | 10.23B | 7.75B | 3.42B | 1.21B | 409.00M |
| Total Liabilities | 23.14B | 20.50B | 19.84B | 14.47B | 11.38B | 9.21B |
| Stockholders Equity | 67.74B | 70.62B | 76.23B | 67.42B | 61.34B | 54.35B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.44B | 5.11B | 4.51B | 1.25B | 1.47B |
| Operating Cash Flow | 0.00 | 12.04B | 12.93B | 11.61B | 6.69B | 6.23B |
| Investing Cash Flow | 0.00 | -8.78B | -9.09B | -8.18B | -6.25B | -4.88B |
| Financing Cash Flow | 0.00 | -5.50B | 2.31B | 516.00M | -1.61B | -1.38B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥720.03B | 26.71 | 13.15% | 0.23% | 2.66% | 7.90% | |
78 Outperform | ¥425.77B | 9.21 | 11.96% | 3.04% | 2.70% | ― | |
78 Outperform | ¥676.50B | 15.50 | 8.07% | 2.85% | 11.18% | -0.75% | |
74 Outperform | ¥6.98T | 59.16 | 8.95% | 1.88% | 2.88% | 28.76% | |
70 Outperform | ¥78.39B | 10.57 | ― | 3.05% | 10.79% | 12.28% | |
64 Neutral | ¥164.28B | 29.59 | 5.91% | 2.39% | -3.24% | -25.21% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |